Match!
Olivia M. Farr
Beth Israel Deaconess Medical Center
50Publications
20H-index
938Citations
Publications 52
Newest
#1Chrysoula Boutari (BIDMC: Beth Israel Deaconess Medical Center)H-Index: 6
#2Eirini Bouzoni (BIDMC: Beth Israel Deaconess Medical Center)H-Index: 1
Last.Christos S. Mantzoros (Harvard University)H-Index: 106
view all 6 authors...
1 CitationsSource
#1Bridget DiPrisco (Boston Children's Hospital)H-Index: 1
#2Arvind KumarH-Index: 105
Last.Christos S. Mantzoros (Harvard University)H-Index: 106
view all 9 authors...
Abstract Objective: Preeclampsia is a common disorder of pregnancy, causing significant morbidity and mortality for mothers and infants. Several molecules, including glycosylated fibronectin (GlyFn...
Source
#1Natia Peradze (BIDMC: Beth Israel Deaconess Medical Center)H-Index: 2
#2Olivia M. Farr (BIDMC: Beth Israel Deaconess Medical Center)H-Index: 20
Last.Christos S. Mantzoros (Harvard University)H-Index: 106
view all 6 authors...
Long-term treatment with up to 1.8 mg liraglutide improves cardiovascular and all-cause mortality in patients with type 2 diabetes at high risk for cardiovascular disease (CVD) and is currently under investigation in subjects without diabetes. Aim of our study was to investigate whether high dose (3 mg) short-term (5 weeks) treatment with liraglutide in obese patients with no overt type 2 diabetes affects metabolites, lipid and lipoprotein profile and components of activin–follistatin axis in ca...
Source
#1Bridget DiPrisco (Boston Children's Hospital)H-Index: 1
#2Ajay KumarH-Index: 82
Last.Christos S. Mantzoros (Harvard University)H-Index: 106
view all 9 authors...
Abstract Background A newborn's birth weight for gestational age provides important insights into his or her fetal growth and well-being. While the underlying mechanisms regulating fetal growth remain to be fully elucidated, the IGF-axis plays an important role. Some components of this axis have been well-characterized in umbilical cord blood, but others have not yet been studied. We measured the proteases PAPP-A and PAPP-A2, the binding proteins they cleave (IGFBP-4 and -5), and the established...
Source
#1Olivia M. Farr (BIDMC: Beth Israel Deaconess Medical Center)H-Index: 20
#2Christos S. Mantzoros (Harvard University)H-Index: 106
Source
#1Dario Tuccinardi (Harvard University)H-Index: 2
#2Olivia M. Farr (Harvard University)H-Index: 20
Last.Christos S. Mantzoros (Harvard University)H-Index: 106
view all 13 authors...
Aims: To assess the effects of walnuts on cardiometabolic outcomes in obese people and to explore the underlying mechanisms using novel methods including metabolomic, lipidomic, glycomic and microbiome analysis, integrated with lipid particle fractionation, appetite-regulating hormones and haemodynamic measurements. Materials and Methods: A total of 10 obese individuals were enrolled in this cross-over, randomized, double-blind, placebo-controlled clinical trial. The participants had two 5-day i...
2 CitationsSource
#1Olivia M. Farr (BIDMC: Beth Israel Deaconess Medical Center)H-Index: 20
#2Eleni Pilitsi (BIDMC: Beth Israel Deaconess Medical Center)H-Index: 1
Last.Christos S. Mantzoros (BIDMC: Beth Israel Deaconess Medical Center)H-Index: 106
view all 3 authors...
Abstract Incretins have risen to the forefront of therapies for obesity and related metabolic complications, primarily because of their efficacy and relatively few side effects. Importantly, their efficacy in altering energy balance and decreasing body weight is apparently through actions in the central nervous system (CNS); the latter may have implications beyond obesity per se, i.e. in other disease states associated with obesity including CNS-related disorders. Here, we first describe the rol...
Source
#1Olivia M. Farr (BIDMC: Beth Israel Deaconess Medical Center)H-Index: 20
#2Jagriti Upadhyay (BIDMC: Beth Israel Deaconess Medical Center)H-Index: 10
Last.Christos S. Mantzoros (BIDMC: Beth Israel Deaconess Medical Center)H-Index: 106
view all 12 authors...
2 CitationsSource
#1Dario Tuccinardi (BIDMC: Beth Israel Deaconess Medical Center)H-Index: 2
#2Olivia M. Farr (BIDMC: Beth Israel Deaconess Medical Center)H-Index: 20
Last.Christos S. Mantzoros (BIDMC: Beth Israel Deaconess Medical Center)H-Index: 106
view all 10 authors...
Lorcaserin is a serotonin 2c receptor agonist that promotes weight loss while contributing to the prevention and improvement of type 2 diabetes and improvement of atherogenic lipid profiles, without higher rates of major cardiovascular events. The full spectrum of possible lorcaserin-induced improvements in cardiometabolic health remains to be clarified. Thus, we investigated the way in which lorcaserin treatment may alter cardiovascular disease risk, either independently or through changes in b...
3 CitationsSource
1 CitationsSource
123456